comparemela.com
Home
Live Updates
SystImmune, Inc. Announces the Presentation of Breast Cancer Clinical Trial Results at the 2023 San Antonio Breast Cancer Conference and US Clinical Trial Developments : comparemela.com
SystImmune, Inc. Announces the Presentation of Breast Cancer Clinical Trial Results at the 2023 San Antonio Breast Cancer Conference and US Clinical Trial Developments
/PRNewswire/ -- SystImmune, Inc (SystImmune), a clinical-stage biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) authorized...
Related Keywords
San Antonio ,
Texas ,
United States ,
Martins Olivo ,
Yi Zhu ,
Prnewswire Systimmune Inc ,
Systimmune Inc ,
While Systimmune Inc ,
Drug Administration ,
European Society For Medical Oncology ,
Securities Exchange ,
Investigational New Drug ,
Chief Executive Officer ,
Antonio Breast Cancer ,
Chief Medical Officer ,
Growth Factor Receptor ,
Neck Squamous Cell Carcinoma ,
European Society ,
Medical Oncology ,
Securities Act ,
Securities Exchange Act ,
Private Securities Litigation Reform Act ,
Systimmune ,
Nc ,
Health Care Amp Hospitals ,
Medical Pharmaceuticals ,
Pharmaceuticals ,
Biotechnology ,
Fda Approval ,
Broadcast Feed Annoucement ,
Clinical Trials Amp Medical Discoveries ,
Trade Show News ,
comparemela.com © 2020. All Rights Reserved.